Get started
Author

Kathryn Ann Kolquist

Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
1998 · Kim E. Nichols, D. Paul Harkin, et al. · Proceedings of the National Academy of Sciences · 500
Expression of TERT in early premalignant lesions and a subset of cells in normal tissues
1998 · Kathryn Ann Kolquist, Leif W. Ellisen, et al. · Nature Genetics · 382
The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin
1999 · Sean Bong Lee, Karen Huang, et al. · Cell · 308
PDF
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
1997 · Sean Bong Lee, Kathryn Ann Kolquist, et al. · Nature Genetics · 179
Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma
2015 · Loren E. Clarke, M.B. Warf, et al. · Journal of Cutaneous Pathology · 156
PDF
An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi
2016 · Loren E. Clarke, Darl D. Flake, et al. · Cancer · 118
PDF
Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes
2011 · Kathryn A. Kolquist, Roger A. Schultz, et al. · Cancer Genetics · 60
FATAL FAT EMBOLISM SYNDROME IN A CHILD WITH UNDIAGNOSED HEMOGLOBIN S/Beta+ THALASSEMIA: A Complication of Acute Parvovirus B19 Infection
1996 · Kathryn A. Kolquist, Cindy L. Vnencak-Jones, et al. · Pediatric Pathology & Laboratory Medicine · 31
The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists
2016 · Clay J. Cockerell, Jaime Tschen, et al. · Medicine · 27
Analytical Validation of a Melanoma Diagnostic Gene Signature Using Formalin-Fixed Paraffin-Embedded Melanocytic Lesions
2015 · M Bryan Warf, Darl D Flake, et al. · Biomarkers in Medicine · 24
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma
2016 · Takashi Eguchi, Kyuichi Kadota, et al. · Oncotarget · 18
Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis
2011 · Kathryn A Kolquist, Roger A Schultz, et al. · Molecular Cytogenetics · 16
PDF
Analytical Validation of a Proliferation-Based Molecular Signature Used as a Prognostic Marker in Early Stage Lung Adenocarcinoma
2015 · M Bryan Warf, Placede G Fosso, et al. · Biomarkers in Medicine · 8
Development and validation of a gene expression signature to distinguish malignant melanoma from benign nevi.
2014 · Colleen Rock, Loren E Clarke, et al. · Journal of Clinical Oncology · 5
Fatal Fat Embolism Syndrome in a Child with Undiagnosed Hemoglobin S/β+ Thalassemia: A Complication of Acute Parvovirus B19 Infection
1996 · Kathryn Kolquist, Cindy Vnencak-Jones, et al. · Fetal and Pediatric Pathology · 4
458 DNA repair deficiencies in ovarian cancer: Genomic analysis of high grade serous ovarian tumors from the NOVA study
2015 · K. Timms, C. Neff, et al. · European Journal of Cancer · 2
FATAL FAT EMBOLISM SYNDROME IN A CHILD WITH UNDIAGNOSED HEMOGLOBIN S/Beta+ THALASSEMIA: A Complication of Acute Parvovirus B19 Infection
1996 · Kathryn Kolquist · Fetal and Pediatric Pathology · 2
Validation of a cell cycle progression score for 5-year mortality risk in patients with stage I non-small cell lung cancer.
2015 · Takashi Eguchi, Kadota Kyuichi, et al. · Journal of Clinical Oncology · 1
The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists.
2014 · Loren E Clarke, Emily Bess, et al. · Journal of Clinical Oncology · 1
Abstract C53: Homologous recombination deficiency (HRD) of high grade serous ovarian tumors from the NOVA Phase III clinical study
2015 · Keith Wilcoxen, Christopher Neff, et al. · Molecular Cancer Therapeutics
Targeted Microarray Analyses Augment the Clinical Cytogenetic Diagnosis of Acute Lymphoblastic Leukemia (ALL): Submicroscopic Genetic Events Improve Diagnosis, Contribute to Risk Stratification, and Provide Genetic Markers for Minimal Residual Disease (MRD) Testing
2010 · Marilyn L. Slovak, Yi Ning, et al. · Blood
Works count: 21
Citation count: 1,842
H-index: 12
I10-index: 12
Year
Topic
Type